Cargando…

Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics

OBJECTIVES: The accurate assessment of liver fibrosis is clinically important in patients with chronic hepatitis B (CHB). Blood tests and elastography are now widely used for the noninvasive diagnosis of liver fibrosis in CHB patients. The aim of this study was to develop a new and more accurate pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin, Wen, Huiying, Zhang, Xinyu, Dong, Changfeng, Lin, Haoming, Guo, Yanrong, Shan, Lingbo, Yao, Simin, Yang, Min, Le, Xiaohua, Liu, Yingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415893/
https://www.ncbi.nlm.nih.gov/pubmed/28383564
http://dx.doi.org/10.1038/ctg.2017.11
_version_ 1783233623396188160
author Chen, Xin
Wen, Huiying
Zhang, Xinyu
Dong, Changfeng
Lin, Haoming
Guo, Yanrong
Shan, Lingbo
Yao, Simin
Yang, Min
Le, Xiaohua
Liu, Yingxia
author_facet Chen, Xin
Wen, Huiying
Zhang, Xinyu
Dong, Changfeng
Lin, Haoming
Guo, Yanrong
Shan, Lingbo
Yao, Simin
Yang, Min
Le, Xiaohua
Liu, Yingxia
author_sort Chen, Xin
collection PubMed
description OBJECTIVES: The accurate assessment of liver fibrosis is clinically important in patients with chronic hepatitis B (CHB). Blood tests and elastography are now widely used for the noninvasive diagnosis of liver fibrosis in CHB patients. The aim of this study was to develop a new and more accurate predictive model, which combines elastography data, serum biomarkers, and individual characteristics, to discriminate between CHB patients with and without significant liver fibrosis. METHODS: Two noninvasive methods, specifically, an ultrasound elastography technique termed acoustic radiation force impulse imaging (ARFI) and a blood test, were used to assess a cohort of 345 patients (estimation group, 218 patients; validation group, 127 patients) with CHB. Multivariate logistic regression analysis revealed that ARFI, the aspartate aminotransferase (AST) to platelet ratio, and age were significantly associated with fibrosis. Based on these results, we constructed and validated a model for the diagnosis of significant hepatic fibrosis. RESULTS: The area under the receiver operating characteristic (ROC) curve was 0.921 for the estimation group and 0.929 for the validation group, significantly higher than those for ARFI (0.887, 0.893) and for the AST-to-platelet ratio index (APRI; 0.811, 0.859). Using an optimal cutoff of 3.05 in the validation group, all the indices of the proposed model, including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio, were better than those for ARFI or APRI. CONCLUSIONS: We developed a simple noninvasive model that used ultrasound elastography, routine serum biomarkers, and individual characteristics to accurately differentiate significant fibrosis in patients with CHB. Compared with elastography or the biomarker index alone, this model was significantly more accurate and robust.
format Online
Article
Text
id pubmed-5415893
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54158932017-05-17 Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics Chen, Xin Wen, Huiying Zhang, Xinyu Dong, Changfeng Lin, Haoming Guo, Yanrong Shan, Lingbo Yao, Simin Yang, Min Le, Xiaohua Liu, Yingxia Clin Transl Gastroenterol Original Contributions OBJECTIVES: The accurate assessment of liver fibrosis is clinically important in patients with chronic hepatitis B (CHB). Blood tests and elastography are now widely used for the noninvasive diagnosis of liver fibrosis in CHB patients. The aim of this study was to develop a new and more accurate predictive model, which combines elastography data, serum biomarkers, and individual characteristics, to discriminate between CHB patients with and without significant liver fibrosis. METHODS: Two noninvasive methods, specifically, an ultrasound elastography technique termed acoustic radiation force impulse imaging (ARFI) and a blood test, were used to assess a cohort of 345 patients (estimation group, 218 patients; validation group, 127 patients) with CHB. Multivariate logistic regression analysis revealed that ARFI, the aspartate aminotransferase (AST) to platelet ratio, and age were significantly associated with fibrosis. Based on these results, we constructed and validated a model for the diagnosis of significant hepatic fibrosis. RESULTS: The area under the receiver operating characteristic (ROC) curve was 0.921 for the estimation group and 0.929 for the validation group, significantly higher than those for ARFI (0.887, 0.893) and for the AST-to-platelet ratio index (APRI; 0.811, 0.859). Using an optimal cutoff of 3.05 in the validation group, all the indices of the proposed model, including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio, were better than those for ARFI or APRI. CONCLUSIONS: We developed a simple noninvasive model that used ultrasound elastography, routine serum biomarkers, and individual characteristics to accurately differentiate significant fibrosis in patients with CHB. Compared with elastography or the biomarker index alone, this model was significantly more accurate and robust. Nature Publishing Group 2017-04 2017-04-06 /pmc/articles/PMC5415893/ /pubmed/28383564 http://dx.doi.org/10.1038/ctg.2017.11 Text en Copyright © 2017 the American College of Gastroenterology http://creativecommons.org/licenses/by-nc-nd/4.0/ Clinical and Translational Gastroenterology is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Original Contributions
Chen, Xin
Wen, Huiying
Zhang, Xinyu
Dong, Changfeng
Lin, Haoming
Guo, Yanrong
Shan, Lingbo
Yao, Simin
Yang, Min
Le, Xiaohua
Liu, Yingxia
Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title_full Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title_fullStr Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title_full_unstemmed Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title_short Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics
title_sort development of a simple noninvasive model to predict significant fibrosis in patients with chronic hepatitis b: combination of ultrasound elastography, serum biomarkers, and individual characteristics
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415893/
https://www.ncbi.nlm.nih.gov/pubmed/28383564
http://dx.doi.org/10.1038/ctg.2017.11
work_keys_str_mv AT chenxin developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT wenhuiying developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT zhangxinyu developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT dongchangfeng developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT linhaoming developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT guoyanrong developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT shanlingbo developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT yaosimin developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT yangmin developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT lexiaohua developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics
AT liuyingxia developmentofasimplenoninvasivemodeltopredictsignificantfibrosisinpatientswithchronichepatitisbcombinationofultrasoundelastographyserumbiomarkersandindividualcharacteristics